Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inspection Of Rx Imports Would Climb Under Bill Setting $300 Mil. In User Fees

Executive Summary

Drug import fees totaling $300 million each in fiscal years 2008 through 2012 would be authorized by a food and drug import safety bill being developed by House Energy and Commerce Committee Chairman John Dingell, D-Mich

You may also be interested in...



U.S. FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains

FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain

FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains

FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain.

FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains

FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS048670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel